Galectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in Philadelphia
October 17 2016 - 8:30AM
Galectin Therapeutics (NASDAQ:GALT), the leading developer of
therapeutics that target galectin proteins to treat fibrosis and
cancer, today announced that Peter G. Traber, M.D., the company's
president, chief executive officer and chief medical officer, will
present at The MicroCap Conference on Tuesday, October 25, 2016 at
8:30 a.m. ET. The conference is being held in Philadelphia,
Pennsylvania at the Hotel Monaco.
The MicroCap Conference is an exclusive event for investors who
specialize in small microcap stocks. It is an opportunity to be
introduced to and speak with management at some of the most
attractive small companies, learn from various expert panels, and
mingle with other microcap investors. If you are a private investor
or institutional investor interested in learning more about the
conference, visit
http://microcapconf.com/conferences/philadelphia-2016/.
A live webcast of the presentation may be accessed on the
conference’s website at http://wsw.com/webcast/microcapconf2/galt.
The webcast and presentation will be archived for 90 days following
the event on the company’s website at
www.galectintherapeutics.com.
About Galectin Therapeutics Galectin
Therapeutics is developing promising therapies for the treatment of
fibrotic liver disease and cancer based on the Company's unique
understanding of galectin proteins, which are key mediators of
biologic function. Galectin seeks to leverage extensive scientific
and development expertise as well as established relationships with
external sources to achieve cost-effective and efficient
development. The Company is pursuing a development pathway to
clinical enhancement and commercialization for its lead compounds
in liver fibrosis and cancer. Additional information is available
at www.galectintherapeutics.com.
Contacts:
Jack Callicutt, Chief Financial Officer
(678) 620-3186
ir@galectintherapeutics.com.
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Apr 2023 to Apr 2024